Grain-Free vs. Grain-Inclusive Pet Food: What Buyers Should Actually Know
Grain-free is a formulation choice, not a regulatory claim category with its own substantiation requirement — but it carries more baggage than most label claims because of an unresolved FDA investigation buyers should understand honestly before sourcing either direction. This guide covers what's actually settled, what isn't, and the sourcing tradeoffs beyond the health-claim debate.
Grain-free isn't a regulated claim category the way 'organic' or 'human grade' is
Unlike organic certification or AAFCO's Human Grade standard, there's no dedicated substantiation framework a manufacturer has to clear to call a product grain-free — it's simply a truthful ingredient statement, provided the formulation genuinely contains no grain ingredients. Both grain-free and grain-inclusive formulas still have to meet the same underlying AAFCO or FEDIAF nutrient-adequacy profile for their labelled life stage — grain content is a formulation and ingredient-sourcing decision layered on top of that same baseline requirement, not a separate compliance track.
The FDA DCM investigation, stated plainly
In 2018 the FDA opened an investigation into a possible link between certain diets — disproportionately grain-free formulas — and canine dilated cardiomyopathy (DCM), a serious heart condition. The FDA's last public update was published in December 2022, stating investigators had insufficient data to establish causality between the reported cases and specific pet food products. The FDA has not issued a further public update since. University veterinary cardiology programmes (Tufts, UC Davis, Cornell among others) have continued publishing DCM case research through 2023-2025, so this remains a genuinely open scientific question rather than a closed one in either direction — buyers should represent it that way, not as either a settled risk or a fully cleared non-issue.
What this means for label claims and marketing
Given the unresolved investigation, buyers sourcing grain-free product should avoid marketing language implying a health or safety benefit over grain-inclusive formulas — that's an unsubstantiated claim on an open scientific question, not a defensible label statement. A truthful ingredient-list claim ('grain-free,' listing the actual starch source used instead) is a different, safer thing than an implied health-superiority claim, and buyers should be precise about which one their packaging actually makes.
Nutrient adequacy: the same standard applies to both
Both grain and grain-free formulas are tested against the same AAFCO nutrient minimums for their life stage — for example, the adult maintenance methionine-cystine minimum of 0.65% applies regardless of whether the recipe's carbohydrate source is rice, corn, or a legume-based alternative used in grain-free formulations. A well-formulated product in either category should clear the same nutrient-adequacy bar; the difference is the ingredient source used to hit it, not a different or lower bar for one category.
Have questions before you keep reading?
Get pricing, MOQs and lead times for your market.
Ingredient sourcing differences between the two
Grain-inclusive formulas typically source carbohydrate from rice, corn, wheat, or oats; grain-free formulas substitute legumes (peas, lentils, chickpeas), potatoes, or sweet potatoes as the primary starch source. This has real sourcing and cost implications independent of the health-claim question — legume and alternative-starch ingredient costs and supply reliability can differ meaningfully from commodity grain sourcing, and buyers should evaluate ingredient supply-chain stability for whichever formulation direction they choose, not just the finished-product price quote.
Market demand and positioning
Grain-free remains a meaningful consumer demand segment in both US and EU markets despite the open DCM question, often positioned around allergy-sensitivity or ancestral-diet consumer narratives rather than a direct health claim — buyers should distinguish between sourcing to genuine consumer demand for grain-free product (a legitimate commercial decision) and implying an unsubstantiated health benefit in how it's marketed (a labelling risk to avoid).
Cost and formulation complexity
Grain-free formulations can carry a modest cost premium over grain-inclusive equivalents, driven by alternative-starch ingredient costs rather than any difference in production process — both formats use the same extrusion or wet-food production methods. Buyers should get ingredient-cost breakdowns specific to their target formulation rather than assuming a fixed price differential applies universally across manufacturers and ingredient sourcing regions.
When grain-inclusive fits
Grain-inclusive fits buyers prioritising the most stable, cost-predictable commodity ingredient sourcing, a straightforward label-claim position with no open scientific question to navigate, and value-tier price positioning where every input cost matters.
Ready to move forward?
Connect with our team to structure your order, timeline and volumes.
When grain-free fits
Grain-free fits buyers sourcing specifically to documented consumer demand for grain-free product or targeting allergy-sensitivity positioning, provided the label makes only truthful ingredient claims rather than implied health-superiority claims given the DCM investigation remains open.
Common mistakes buyers make with grain claims
The most common mistake is marketing grain-free with implied health-superiority language given the FDA investigation has not concluded in either direction — this is an avoidable labelling risk, not a necessary part of selling into the grain-free segment. The second is assuming grain-free formulations face a different or additional AAFCO/FEDIAF substantiation process; they don't — both categories clear the same nutrient-adequacy bar the same way.
How Candora Petcare supports grain claim sourcing decisions
Candora Petcare works with manufacturers producing both grain-inclusive and grain-free formulations to the same AAFCO/FEDIAF nutrient-adequacy standard, helping buyers source to genuine market demand while keeping label claims honest about what remains an open scientific question.
FAQ
Frequently asked questions
It's an open question — the FDA's investigation into a possible link to canine DCM has not concluded; its last public update (December 2022) cited insufficient data to establish causality, while university cardiology research has continued publishing case data through 2023-2025.
No — both are tested against the same nutrient-adequacy minimums for their life stage. Grain content is a formulation and ingredient-sourcing choice, not a separate compliance track.
No — that implies a health-superiority claim on an unresolved scientific question. A truthful ingredient-list statement is defensible; an implied health benefit claim is a labelling risk worth avoiding.
Typically legumes (peas, lentils, chickpeas), potatoes, or sweet potatoes as the primary starch source, replacing rice, corn, wheat, or oats.
Often a modest premium, driven by alternative-starch ingredient costs rather than a different production process — get ingredient-cost breakdowns specific to your target formulation rather than assuming a fixed differential.
Yes, in both US and EU markets, often tied to allergy-sensitivity or ancestral-diet positioning rather than a direct health claim — a legitimate commercial reason to source grain-free, separate from any implied health-superiority marketing.
Grain-inclusive generally offers the most cost-predictable commodity sourcing and the most straightforward label-claim position for a first range; grain-free suits buyers with documented demand for that specific positioning.
Ready to get started?
Contact our team to discuss volumes, pricing, and supply structures for your market.
Related
